Methods of reducing eosinophil levels

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 7/00 (2006.01) A61P 37/08 (2006.01)

Patent

CA 2685222

The present invention relates to a method of reducing the numbers of eosinophils in a human subject comprising administration to a subject an IL-5R binding molecule that comprises (a) a region that specifically binds to the IL-5R and (b) an immunoglobulin Fc region. In a specific embodiment, a method of the invention reduces the number of eosinophils in blood, bone marrow, gastrointestinal tract (e g, esophagus, stomach, small intestine and colon), or lung.

La présente invention concerne une méthode de réduction du nombre d'éosinophiles chez un sujet humain. Ladite méthode comporte l'administration à un sujet d'une molécule de liaison au récepteur de l'IL-5 qui comprend: (a) une région qui se lie spécifiquement au récepteur de l'IL-5 et (b) une région Fc de l'immunoglobuline. Dans un mode de réalisation spécifique, une méthode de l'invention réduit le nombre d'éosinophiles dans le sang, la moelle osseuse, le tractus gastro-intestinal (par ex., l'oesophage, l'estomac, l'intestin grêle et le côlon), ou le poumon.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of reducing eosinophil levels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of reducing eosinophil levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of reducing eosinophil levels will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1464480

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.